Skip to main content

Table 2 Demographics and clinical characteristics in the PP Population

From: The dynamics of the metabolism of acetate and bicarbonate associated with use of hemodialysates in the ABChD trial: a phase IV, prospective, single center, single blind, randomized, cross-over, two week investigation

Parameter Statistic NaturaLyte GranuFlo Total (All Treated)
Patient number (Per Protocol Population) N 10 10 11
Age (years) Mean (SD) 53.1 (10.82) 54.9 (8.77) 53.1 (10.26)
Median 50.5 52 51
Min, Max 35.0, 75.0 47.0, 75.0 35.0, 75.0
Sex
 Female n (%) 3 (30.0) 4 (40.0) 4 (36.4)
 Male n (%) 7 (70.0) 6 (60.0) 7 (63.6)
Race
 American Indian or Alaska Native n (%) 0 (0.0) 0 (0.0) 0 (0.0)
 Asian n (%) 0 (0.0) 0 (0.0) 0 (0.0)
 Black n (%) 8 (80.0) 9 (90.0) 9 (81.8)
 Native Hawaiian or other Pacific Islander n (%) 0 (0.0) 0 (0.0) 0 (0.0)
 White n (%) 2 (20.0) 1 (10.0) 2 (18.2)
Ethnic Group
 Hispanic or Latino n (%) 0 (0.0) 0 (0.0) 0 (0.0)
 Not Hispanic or Latino n (%) 10 (100.0) 10 (100.0) 11 (100.0)
Weight (kg) Mean (SD) 84.4 (20.35) 88.1 (23.09) 87.6 (21.99)
Median 82.1 88.5 82.3
Min, Max 50.5, 120.3 50.5, 120.3 50.5, 120.3
Height (cm) Mean (SD) 164.5 (10.85) 167.4 (11.06) 166.0 (11.45)
Median 162.7 168.3 166.4
Min, Max 151.9, 185.9 151.9, 185.9 151.9, 185.9
BMI (kg/m2) Mean (SD) 31.2 (7.32) 31.3 (7.39) 31.7 (7.12)
Median 31.3 31.3 32.1
Min, Max 21.9, 47.6 21.9, 47.6 21.9, 47.6